Skip to main content
Premium Trial:

Request an Annual Quote

Sirigen Raises $6.1M for Technology Commercialization

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK amplification firm Sirigen today announced it has raised about £3.8 million ($6.1 million) in two completed rounds of financing, which it will use to support commercialization of its High Sensitivity Fluorescence technology.

Leading the rounds was a syndicate of new investors including IQ Capital, the National Endowment for Science, Technology, and the Arts, and YFM Private Equity. Existing investors Seraphim Capital and Oxford Capital Partners also participated.

According to Sirigen's website, its HSF technology overcomes fluorescent detection's dependence on the performance of reporter dyes that are used and their ability to absorb excitation light. The HSF polymers are designed "for maximal absorption of exciting light and conversion to fluorescent signal."

The firm said that its technology can be used in a wide range of assay formats and applications including multiplex and molecular diagnostics, microarrays, and DNA sequencing.

The company also announced that Ivan Griffin at NESTA and Max Bautin at IQ Capital have been appointed investor directors at Sirigen. David Evans was appointed chairman of the board and Arthur Cole was appointed as a non-executive director.

Evans is the former CFO of Shield Diagnostics and is chairman and non-executive director at a number of diagnostic and life science companies. He also was chairman of DxS, a molecular diagnostic firm acquired by Qiagen last year.

Cole was executive vice president of Visible Genetics and vice president of new business development at Pharmacia Biotech.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.